Effect of the asthma-chronic obstructive pulmonary disease syndrome on the stroke, Parkinson's disease, and dementia: a national cohort study.
Conclusions: The ACOS cohort had a higher risk of the neurodegenerative diseases. The lower dose of the inhaler corticosteroids with cumulative dose ≧0.13 gram have the less risk of stroke and dementia.
PMID: 29552322 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Asthma | Brain | Chronic Obstructive Pulmonary | Corticosteroid Therapy | Databases & Libraries | Dementia | Flonase | Health Insurance | Insurance | Neurology | Parkinson's Disease | Stroke | Study